HOME >> BIOLOGY >> NEWS
Central and peripheral signals set the circadian liver clock

Anyone who has experienced jet lag will understand the importance of a smooth-running circadian clock. Crossing time zones decouples our biological rhythms from the natural cycle of light and dark were used to. We perceive light cues through retinal photoreceptors that relay signals to the suprachiasmatic nucleus (SCN) in the brain. "Phase adjustments" in peripheral tissues ensure that each clock follows the same schedule. These can be set indirectly through SCN-dependent biological rhythms, such as feeding cycles or body temperature. How synchronizing cues operate at the molecular level, however, remains obscure. One key question is whether cyclically expressed genes in peripheral tissues are controlled by local circadian clocks or by systemic cues that are directly or indirectly controlled by the SCN pacemaker.

In a new study published online this week in the open access journal PLoS Biology, Benot Kornmann, Ueli Schibler, and colleagues investigated circadian genes in the liver to try and answer this question. To determine whether genes were under local or systemic control, they generated a mouse strain with conditionally active liver clocks that they could turn on or off at will.

The authors modified a transcription factor called REV-ERBa that shuts down circadian gene expression via suppression of a clock gene Bmal1. The modified gene had tetracycline-responsive elements (TREs), that respond to tetracycline and similar antibiotics. Mice with this modification were bred with a strain carrying a gene construct that activates the elements specifically in liver cells. In transgenic offspring fed with tetracycline-like doxycyline (Dox), Rev-erba remained silent in liver cells and Bmal1 functioned normally. In the absence of Dox, transgenic offspring overexpressed REV-ERBa, and Bmal1 was inactive, effectively turning off the liver clocks.

When the authors performed a genome-wide scan of the expression of genes targeted by BMAL1 in t
'"/>

Contact: Natalie Bouaravong
press@plos.org
415-568-3445
Public Library of Science
29-Jan-2007


Page: 1 2 3

Related biology news :

1. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
2. BioMed Central announces new interdisciplinary Biofuels Journal
3. BioMed Central announces winners of first open access research awards
4. BioMed Central launches BMC Systems Biology, a new open access journal
5. Announcing the launch of Open Access Central
6. EMBL-EBI and collaborators win bid to run UK PubMed Central
7. Impressive new Impact Factors for BioMed Centrals open-access journals
8. BioMed Central launches Biology Direct
9. Six Central European scientists awarded EMBO/HHMI startup grants
10. Central European scientists awarded EMBO/HHMI startup grants
11. Central Americans save plant diversity through local cultivations

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Central and peripheral signals set the circadian liver clock

(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
Cached News: